Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251472
Status:
COMPLETED
Last Update Posted:
2012-05-11
First Post:
2005-11-08
Brief Title:
A Phase II Trial of Abraxane Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
Sponsor:
Organization:
Veeda Oncology